|
PMN
|
And btw, I don't think they have anything to lose by attacking big pharma...
|
|
PMN
|
Perhaps Goldtech will enlighten us all as to what a winning argument might be...
|
|
PMN
|
So nothing to start talking about until early 2025. Means another fall...
|
|
PMN
|
Yeah but 1b is where efficacy starts so until then it might as well be...
|
|
PMN
|
If they didn't want the bump on investor show wouldn't they just have...
|
|
PMN
|
Just a reminder how thin the market really is, and therefore how easy control...
|
|
PMN
|
A competent CEO? What will we talk about?
|
|
PMN
|
oops, guess I totally missed the thread, my bad.
|
|
PMN
|
You mean your pp bet is flatlining? Because nothing has changed, you knew...
|
|
PMN
|
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.13764 https...
|
|
PMN
|
Robert Malone, talking to Jimmy Dore, sums up the FDA gate keeping...
|
|
PMN
|
oops, I meant "wonder weapon", for those following the Ukraine...
|
|
PMN
|
https://www.biopharmadive.com/news/roche-alzheimers-brain-shuttle-trontinemab...
|
|
PMN
|
Upbeat maybe, but fire? What I read still says "don't...
|
|
PMN
|
I guess whoever high closed yesterday is the same as the one dumping today...
|
|
PMN
|
If the market really turns south this year, as I believe it will, then we'...
|
|
PMN
|
I guess when you're paid to write propaganda you slip in the occasional...
|
|
PMN
|
I don't see a problem with this if what they want is minority position...
|
|
PMN
|
Good press release, "Promis will present at ... ". Present at...
|
|
PMN
|
Speaking of nothing, we're now beyond the 85 day 1a study period of the...
|